中国P站

Infective Endocarditis; Pediatric Cardiology; Congenital Heart Disease; Echocardiography; Antibiotic Therapy; Surgical Management; Neonatal Endocarditis; Biomarkers; Prophylaxis; Diagnostic Modalities

Introduction

Pediatric infective endocarditis (IE) is a rare yet significant condition in children, characterized by varied clinical presentations and complex diagnostic challenges. Early recognition and prompt intervention are paramount to improving patient outcomes, particularly for vulnerable populations such as neonates and those with congenital heart disease. Management strategies require a multidisciplinary approach involving various pediatric specialists. The review by Miyagi et al. provides a comprehensive overview of IE in neonates and children, covering epidemiology, risk factors, diagnostic tools, and current management approaches, emphasizing the importance of timely intervention [1].

Infective endocarditis in children presents unique diagnostic hurdles due to non-specific symptoms, necessitating advanced imaging techniques. Bender et al. discuss the management of IE in this age group, highlighting the pivotal role of echocardiography and the impact of different therapeutic strategies, including antibiotic regimens and surgical indications for valve repair or replacement [2].

Identifying the specific pathogens responsible for IE in pediatric patients is critical for effective treatment selection. Liu et al. offer an overview of the common and less common microorganisms implicated in pediatric IE, discussing infection sources, transmission routes, and the clinical manifestations associated with different microbial agents. Their work also touches upon antibiotic susceptibility patterns and their implications for empirical and targeted therapy [3].

The diagnosis of pediatric IE relies heavily on imaging modalities, with echocardiography being a cornerstone. Muthukumar et al. detail the critical role of echocardiography, including transthoracic and transesophageal approaches, in visualizing vegetations and assessing valvular damage. They also discuss the utility of cardiovascular magnetic resonance imaging and computed tomography in complex cases where echocardiography may be inconclusive [4].

Congenital heart disease (CHD) significantly influences the incidence and management of IE in children. Mahle et al. underscore the increased risk of IE in children with structural heart abnormalities, particularly those with prosthetic material or a history of cardiac surgery. They discuss risk stratification, diagnostic nuances, and optimal therapeutic strategies tailored for these complex patients [5].

Updated guidelines provide essential recommendations for the diagnosis and management of IE, with specific attention to the pediatric population. Naccarelli et al. present the 2023 ESC Guidelines, consolidating current evidence on diagnostic criteria, including modifications for children, and outlining therapeutic approaches. Their work emphasizes the role of multidisciplinary teams in decision-making regarding antibiotic therapy and surgical indications [6].

Neonatal infective endocarditis poses distinct and severe challenges due to the extreme vulnerability of this population. Tanoue et al. explore the significant impact of neonatal IE, discussing the unique diagnostic and management complexities, often stemming from non-specific symptoms and intricate cardiac anatomy. They highlight risk factors, etiologies, and specialized therapeutic strategies [7].

Surgical intervention is a crucial component in the management of complicated pediatric IE. Lue et al. present findings on surgical outcomes, evaluating indications, procedure types, and short- and long-term results in children requiring surgery. Their research emphasizes factors influencing prognosis and the necessity of experienced cardiac surgical teams [8].

Biomarkers are increasingly recognized for their diagnostic and prognostic value in pediatric IE. Klingenberg et al. review the utility of various inflammatory and specific markers, such as C-reactive protein, procalcitonin, and pro-brain natriuretic peptide. They discuss how these markers, integrated with clinical and echocardiographic findings, aid in early diagnosis and treatment monitoring [9].

Preventing IE in children, especially those at high risk, is a critical aspect of care. Patel et al. outline current recommendations for antibiotic prophylaxis for dental and other procedures in children with underlying cardiac conditions. Their review discusses the rationale behind prophylaxis, recommended regimens, and the importance of patient and family education in preventing IE [10].

Description

Pediatric infective endocarditis (IE) presents a formidable clinical challenge, requiring a thorough understanding of its epidemiological landscape, risk factors, and diagnostic modalities. Miyagi et al. contribute a 15-year single-center experience, detailing the epidemiology, risk factors, diagnostic pathways including echocardiography, blood cultures, and biomarkers, alongside current management strategies for pediatric IE. Their work underscores the critical need for early recognition and intervention, especially for neonates and children with congenital heart disease, and highlights the importance of multidisciplinary care [1].

The diagnosis of IE in children is often complicated by non-specific symptoms, making advanced imaging techniques indispensable. Bender et al. delve into the management of pediatric IE, emphasizing the crucial role of echocardiography in diagnosis and the impact of various therapeutic approaches. They discuss antibiotic regimens and indications for surgical intervention, focusing on valve repair or replacement in specific cases, and analyze outcomes and complications within their pediatric cohort [2].

Understanding the microbiological etiology of IE is fundamental for guiding appropriate antimicrobial therapy. Liu et al. provide a systematic review and meta-analysis on the microbiological epidemiology of IE in children, identifying common and less common causative microorganisms. Their research details infection sources, transmission routes, and the relationship between microbial agents and clinical presentation, while also discussing antibiotic susceptibility patterns relevant for empirical and targeted treatments [3].

Cardiovascular imaging plays a pivotal role in the diagnosis of pediatric IE. Muthukumar et al. focus on the diagnostic challenges and the application of various imaging techniques, with a particular emphasis on echocardiography (transthoracic and transesophageal) for detecting vegetations and assessing valvular damage. They also evaluate the contribution of cardiovascular magnetic resonance imaging and computed tomography in complex scenarios where echocardiography is inconclusive [4].

Children with congenital heart disease (CHD) represent a particularly vulnerable group susceptible to IE. Mahle et al. examine the interplay between CHD and IE, highlighting that structural heart abnormalities increase risk, especially in the presence of prosthetic material or prior cardiac surgery. Their review addresses specific risk stratification within the CHD population, diagnostic considerations, and optimized antimicrobial and surgical strategies for these complex patients, including considerations for long-term follow-up and recurrence prevention [5].

The European Society of Cardiology (ESC) released updated guidelines in 2023 for the management of IE, with specific considerations for pediatric patients. Naccarelli et al. describe these guidelines, which consolidate current evidence on diagnostic criteria, including adaptations for children, and delineate therapeutic approaches. The importance of a multidisciplinary team in decision-making regarding antibiotic therapy, duration, and surgical indications is strongly emphasized [6].

Neonatal IE is a life-threatening condition that presents unique diagnostic and management challenges. Tanoue et al. report on their 10-year experience with neonatal IE, discussing the specific risk factors, common etiologies, and diagnostic modalities appropriate for this extremely vulnerable population. Their work underscores the high mortality and morbidity associated with neonatal IE and the necessity of specialized neonatal care and cardiac surgical expertise [7].

Surgical intervention for IE in children is often necessary for definitive treatment and carries significant implications for patient outcomes. Lue et al. conducted a systematic review and meta-analysis focusing on the surgical management of pediatric IE. They evaluate indications for surgery, procedural choices (valve repair versus replacement), and both short- and long-term outcomes, identifying factors that influence prognosis, such as the extent of valve damage and the presence of complications [8].

Biomarkers are increasingly integrated into the diagnostic and prognostic assessment of pediatric IE. Klingenberg et al. provide a review of various biomarkers, including inflammatory markers like CRP and procalcitonin, and more specific markers such as pro-BNP. They discuss how these biomarkers, when combined with clinical and echocardiographic data, can enhance early diagnosis, guide treatment decisions, and monitor therapeutic response, while also noting ongoing research into novel biomarkers [9].

Preventive strategies are crucial for reducing the incidence of IE, particularly in high-risk pediatric populations. Patel et al. present an update on the prevention of IE, outlining current recommendations for antibiotic prophylaxis in children with underlying cardiac conditions undergoing dental and other invasive procedures. They discuss the rationale for prophylaxis, recommended regimens, and the importance of patient and family education, while also acknowledging ongoing debates regarding its effectiveness and appropriate indications [10].

Conclusion

Infective endocarditis (IE) in children is a rare but serious condition requiring early recognition and prompt, multidisciplinary intervention. Diagnostic challenges include non-specific symptoms, making advanced imaging like echocardiography crucial. Identifying causative pathogens guides effective antibiotic therapy. Congenital heart disease and neonatal status are significant risk factors. Management strategies involve tailored antibiotic regimens and surgical intervention when necessary, with a focus on valve repair or replacement. Biomarkers aid in diagnosis and prognosis, while prevention through antibiotic prophylaxis is vital for high-risk children. Updated guidelines provide a framework for optimal care.

References

1. Miyagi E, Kimura M, Tsuda T. (2023) .Pediatr Cardiol 44:44.

   , ,

2. Bender J, Sloand J, Kaplan V. (2022) .Semin Pediatr Infect Dis 33:33.

   , ,

3. Liu Y, Zhang L, Li W. (2023) .PLoS One 18:18.

   , ,

4. Muthukumar G, Shaikh A, Ramakrishnan S. (2022) .Heart 108:108.

   , ,

5. Mahle E, Kugler J, Soto G. (2021) .Pediatr Clin North Am 68:68.

   , ,

6. Naccarelli G, Spyridon M, Mendicino L. (2023) .Eur Heart J 44:44.

   , ,

7. Tanoue A, Hashimoto S, Hasegawa M. (2023) .Pediatr Crit Care Med 24:24.

   , ,

8. Lue J, Bader F, Fattal P. (2022) .J Thorac Cardiovasc Surg 164:164.

   , ,

9. Klingenberg C, Habib G, Luz M. (2023) .J Clin Med 12:12.

   , ,

10. Patel N, Lee S, Khan F. (2023) .Cardiol Clin 41:41.

    , ,